Effect of metabolic inhibitors on mesenteric arterial smooth muscle.
D000818:Animals; D001464:Barium / Q000494:pharmacology; D001639:Bicarbonates / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D003486:Cyanides / Q000494:pharmacology; D003864:Depression, Chemical; D004140:Dinitrophenols / Q000494:pharmacology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004492:Edetic Acid / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D005463:Fluoroacetates / Q000494:pharmacology; D007461:Iodoacetates / Q000494:pharmacology; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D008638:Mesenteric Arteries / Q000187:drug effects*; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology; D011773:Pyruvates / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D012965:Sodium Chloride / Q000494:pharmacology; D013268:Stimulation, Chemical; D014439:Tyramine / Q000494:pharmacology
D001639:Bicarbonates; D003486:Cyanides; D004140:Dinitrophenols; D005463:Fluoroacetates; D007461:Iodoacetates; D011453:Prostaglandins; D011773:Pyruvates; D001464:Barium; D012701:Serotonin; D012965:Sodium Chloride; D004492:Edetic Acid; D008274:Magnesium; D011188:Potassium; D002118:Calcium; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine